News
The company is positioning BE-Smart for near-term commercialization, targeting the $10 billion esophageal disease testing ...
Medison, the creator of a first-of-its-kind unified global commercialization platform that accelerates the launch of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results